The psoriasis treatment market is projected to reach USD 32.46 billion in 2025, driven by the rising prevalence of psoriasis and autoimmune disorders. With growing demand for biologic therapies, immunomodulators, and innovative topical treatments, the market is expected to expand to USD 71.62 billion by 2033 at a CAGR of 10.40%. This episode explores advancements in targeted biologics, JAK inhibitors, and personalized dermatology treatments revolutionizing psoriasis care.